isoalantolactone has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Huang, H; Li, P; Liu, Y; Yang, Y; Ye, X; Zhang, F | 1 |
| Ali, M; Di, J; Li, J; Li, X; Malhi, M; Millimouno, FM; Rasul, A; Tsuji, I | 1 |
2 other study(ies) available for isoalantolactone and Cancer of Prostate
| Article | Year |
|---|---|
Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells.
Topics: Animals; Cell Line, Tumor; Endoplasmic Reticulum Stress; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Random Allocation; Reactive Oxygen Species; Sesquiterpenes; STAT3 Transcription Factor | 2018 |
Reactive oxygen species mediate isoalantolactone-induced apoptosis in human prostate cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Humans; Male; Membrane Potential, Mitochondrial; Prostatic Neoplasms; Reactive Oxygen Species; Sesquiterpenes | 2013 |